Guardant Health: Manuel Hidalgo Medina

Guardant Health has appointed Manuel Hidalgo Medina to its board of directors, effective immediately. Hidalgo currently serves as chief of hematology and medical oncology at Weill Cornell Medicine and New York-Presbyterian/Weill Cornell Medical Center. His career includes prior roles as chief of the division of hematology at Beth Israel Deaconess Medical Center in Boston, clinical director of the Rosenberg Clinical Cancer Center, and leadership positions at the Spanish National Cancer Research Centre (CNIO) in Madrid and the Kimmel Comprehensive Cancer Center. He is also a member of the board at Bristol Myers Squibb.